KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Non Operating Income (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Non Operating Income data on record, last reported at -$24.2 million in Q4 2025.

  • For Q4 2025, Non Operating Income fell 5.22% year-over-year to -$24.2 million; the TTM value through Dec 2025 reached $8.7 million, down 30.95%, while the annual FY2025 figure was $8.7 million, 87.37% down from the prior year.
  • Non Operating Income reached -$24.2 million in Q4 2025 per EW's latest filing, down from $41.3 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $53.2 million in Q4 2023 and bottomed at -$24.2 million in Q4 2025.
  • Average Non Operating Income over 5 years is $6.0 million, with a median of $4.3 million recorded in 2022.
  • Peak YoY movement for Non Operating Income: skyrocketed 1566.67% in 2021, then plummeted 650.0% in 2025.
  • A 5-year view of Non Operating Income shows it stood at $4.4 million in 2021, then skyrocketed by 31.82% to $5.8 million in 2022, then soared by 817.24% to $53.2 million in 2023, then tumbled by 143.23% to -$23.0 million in 2024, then decreased by 5.22% to -$24.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were -$24.2 million in Q4 2025, $41.3 million in Q3 2025, and -$11.0 million in Q2 2025.